Russell Investments Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.2M | Sell |
134,939
-23,336
| -15% | -$1.25M | 0.01% | 1010 |
|
|
2025
Q1 | $6.41M | Buy |
158,275
+156,223
| +7,613% | +$6.32M | 0.01% | 1025 |
|
|
2024
Q4 | $57.1K | Sell |
2,052
-141
| -6% | -$3.92K | ﹤0.01% | 2791 |
|
|
2024
Q3 | $62.9K | Buy |
2,193
+761
| +53% | +$21.8K | ﹤0.01% | 2745 |
|
|
2024
Q2 | $33.6K | Buy |
1,432
+199
| +16% | +$4.67K | ﹤0.01% | 2849 |
|
|
2024
Q1 | $31.1K | Buy |
1,233
+1,183
| +2,366% | +$29.9K | ﹤0.01% | 2725 |
|
|
2023
Q4 | $1.17K | Buy |
50
+31
| +163% | +$724 | ﹤0.01% | 3050 |
|
|
2023
Q3 | $961 | Hold |
19
| – | – | ﹤0.01% | 3342 |
|
|
2023
Q2 | $887 | Sell |
19
-82
| -81% | -$3.83K | ﹤0.01% | 3332 |
|
|
2023
Q1 | $3.86K | Buy |
+101
| New | +$3.86K | ﹤0.01% | 2967 |
|
|
2020
Q4 | – | Sell |
-11,782
| Closed | -$362K | – | 3025 |
|
|
2020
Q3 | $362K | Sell |
11,782
-865
| -7% | -$26.6K | ﹤0.01% | 2538 |
|
|
2020
Q2 | $314K | Buy |
+12,647
| New | +$314K | ﹤0.01% | 2565 |
|